Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073903 · ClinicalTrials.gov registry record
The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC
A clinical trial of Inpatients With Limited English Proficiency, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT02073903 is a study of Inpatients With Limited English Proficiency that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02073903, a study of Inpatients With Limited English Proficiency, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectiveness with this technology.
Conditions Studied
Interventions
- BEHAVIORAL Patient Survey
- BEHAVIORAL Provider Survey
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-02-24 |
| Est. Completion | 2020-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02073903
The ClinicalTrials.gov registry entry for NCT02073903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Inpatients With Limited English Proficiency appearing as the primary indexed condition, and to 2 interventions - of which Patient Survey is the first listed.
NCT02073903 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02073903 about?
NCT02073903 is a clinical study titled "The Use of Dual-handset Interpreter Phones in an Inpatient Setting to Improve Communication With Limited English Proficiency Patients at MSKCC". The purpose of this study is to introduce new technology and interpreter practices in the inpatient setting at MSKCC. We plan to install dual handset phones at the bedsides of limited English proficiency (LEP) patients and to assess the impact on both patient and physician communication effectivenes...
What is the current status of trial NCT02073903?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2014-02-24. Estimated completion is 2020-01-08.
What conditions does trial NCT02073903 study?
This clinical trial studies the following conditions: Inpatients With Limited English Proficiency.
What interventions are being tested in trial NCT02073903?
The interventions under investigation include: Patient Survey (BEHAVIORAL), Provider Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT02073903?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02073903 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.